Report #2843256

Overview

Sex

Male

Age

Age unknown

State

FL

Recovered

Unknown

Vaccinated

Mar 14, 2024

Onset

Mar 14, 2025

Days to onset

365

Hospital days

—

Symptoms (2)

Symptom narrative

No adverse event; Patient received PROQUAD dose on 3/14/2024, 1/31/2025 and on 3/14/2025; This spontaneous report was received from a medical assistant on 13-MAY-2025 and refers to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. Historical vaccines include Measles, mumps, and rubella virus vaccine live (MMRII) and Varicella virus vaccine live (Oka/Merck) (VARIVAX) ad mistered on 01-FEB-2024. On 14-MAR-2024 at another clinic, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot#, expiration date, dose number, anatomical location, route of administration were not reported) and with sterile diluent (MERCK STERILE DILUENT) (lot#, expiration date, dose number, anatomical location, route of administration were not reported) for Prophylaxis. The Medical assistant reported that on 31-JAN-2025 and 14-MAR-2025 , the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y015355, expiration date: 10-MAR-2026), dose 0.5 mL (conflicting information reported as first and second dose respectively by the same reporter) (dose number, anatomical location, route of administration were not reported) and with sterile diluent (MERCK STERILE DILUENT) for prophylaxis (Extra dose administered). No additional adverse event or quality complaint was reported. No additional Adverse events reported.